TDI Expert Meeting 25-26 September 2006

TDI Expert Meeting 25-26 September 2006

Data quality and data coverage within the Treatment Demand Indicator. Drug use among very young people in treatment for drug use. 6thAnnual Expert Meeting on TDI. Final minutes. EMCDDA - Lisbon. Tables of contents. State of Progress of the Treatment Demand Indicator.

Decisions Taken in the 84Th Meeting of the Genetic Engineering Approval Committee Held on 2

Decisions Taken in the 84Th Meeting of the Genetic Engineering Approval Committee Held on 2

Decisions taken in the 84thMeeting of the Genetic Engineering Approval Committee held on 2.5.2008. The 84thmeeting of the Genetically Engineering Approval Committee (GEAC) was held on 2.5.2008 in Room No. 623 in the Ministry of Environment and Forests.

Online Supplemental File 1

Online Supplemental File 1

Online supplemental file 1. Section A: Points to consider when establishing a biologics register. Purpose of the biologics register. Observational drug registers have many potential benefits, including real-life assessment of drug effectiveness and safety.

Please Fill out All of the Sections That Are Relevant to You Request

Please Fill out All of the Sections That Are Relevant to You Request

Irving Institute for Clinical and Translational Research. Clinical ResearchCenter. APPLICATION FOR USE OF RESOURCES. St. Luke s-Roosevelt Hospital Center CRC.

LLU Institutional Review Board

LLU Institutional Review Board

NEOMED Institutional Review Board. Guidelines for Protection of Human Subjects in Research. Office of Research and Sponsored Programs. NEOMED s Institutional Review Board (IRB) is an administrative body established to protect the.

2015 Small Steps Pt Letter

2015 Small Steps Pt Letter

Dear Friends and Patients of Upper Cervical Care. Each year our professional research association, the Upper Cervical Research Foundation conducts a month long fundraiser called Small Steps to Success . This year, our 7th annual Small Steps Campaign runs.

Performance in Initiating Clinical Research

Performance in Initiating Clinical Research

Research & Development Performance in Initiating & Delivering Research January, 2016. This document has been produced in line with guidance provided by the National Institute for Health Research (NIHR). It details the performance of clinical research.

Biomedical Research Ethics

Biomedical Research Ethics

Biomedical Research Ethics. Please place a check mark by those descriptions you feel are ethical decisions. If you feel the decision was not ethical, briefly write the reason below the question.

Raising Polyclonal Antibodies Against Mycobacterium Toxoid, in Laboratory Animals

Raising Polyclonal Antibodies Against Mycobacterium Toxoid, in Laboratory Animals

RAISING POLYCLONAL ANTIBODIES AGAINST MYCOBACTERIUM TOXOID IN LABORATORY ANIMALS. PROTOCOL FOR M.PHARM. RAJIVGANDHIUNIVERSITY OF HEALTH SCIENCES. BANGALORE, KARNATAKA. DEPARTMENT OF PHARMACEUTICAL BIOTECHNOLOGY. BHARATHICOLLEGE OF PHARMACY. UNDER THE GUIDENCE OF. Dr.GURUKAR MATHEW.S,Ph.D.

Exemption Screening Questions

Exemption Screening Questions

* An IRB number will be assigned to your protocol for tracking purposes when it is received in the IRB office. IRB Form for Non-Course-Based Research. EXEMPTION SCREENING QUESTIONS.

University Hospital of Brooklyn

University Hospital of Brooklyn

SUNY DOWNSTATE MEDICAL CENTER. UNIVERSITY HOSPITAL OF BROOKLYN. POLICY AND PROCEDURE. Policy and Purpose. Ethical Principles in Human Research. Acronyms and Definitions. Determining Whether IRB Approval is Required. Activities Requiring IRB Review and Approval.

Investigational Drug Study Registry Form

Investigational Drug Study Registry Form

INVESTIGATIONAL DRUG STUDY REGISTRY FORM. DEPARTMENT OF PHARMACEUTICAL AND NUTRITION CARE. THE NEBRASKAMEDICALCENTERHOSPITAL AND CLINIC. AND UNIVERSITY OF NEBRASKAMEDICALCENTER. To maintain compliance with both Medical Staff Policy No. 5 III and the.

UWS Ethics Committee

UWS Ethics Committee

Research Integrity. A Policy Framework on Research Ethics. Institutional Structure. College Structure. Determining whether Ethical Approval is Required. Procedures on Quality Checks and Assurance. Obligations of Principal Investigators. Health & Social Care Research. Research Governance Framework.

Emergency Use of an Investigational New Drug

Emergency Use of an Investigational New Drug

Emergency Use of a Drug, Biologic or Device. This document provides guidance to physicians who have an emergency needto use an investigational (non-FDA-approved) drug, biologic, or device in themedical care of a patient. This procedure applies solely.

Worksheet for Submitting a New

Worksheet for Submitting a New

VAMHCS Research Service. Worksheet for Submitting a New. Human Subjects Research Project. IRB Determination. Full Board Exempt Expedited NHSRVA Central-IRB. VA Grant Funded BREF Funded No Funding University/Other. GENERAL INFORMATION. Principal Investigator.

Emergency Use Guidelines

Emergency Use Guidelines

EMERGENCY USE GUIDELINES. Definition of Emergency Use. Emergency Use is defined as the use of a test article on a human subject in a life-threatening situation in which no standard acceptable treatment is available and in which there is not sufficient time to obtain IRB approval 21 CFR 56.102(d).